UiPath Inc (PATH) Stock: Analyzing the Market Value

Biotech Stocks to buy

The 36-month beta value for PATH is at 1.06. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 18 as “hold,” and 1 as “sell.”

The public float for PATH is 407.88M, and currently, shorts hold a 11.06% of that float. The average trading volume for PATH on June 09, 2025 was 14.31M shares.

PATH) stock’s latest price update

UiPath Inc (NYSE: PATH) has experienced a decline in its stock price by -0.38 compared to its previous closing price of 13.26. However, the company has seen a fall of -0.75% in its stock price over the last five trading days. zacks.com reported 2025-06-05 that PATH rides strong enterprise demand and key tech alliances to stay ahead in the fast-growing RPA market.

PATH’s Market Performance

PATH’s stock has fallen by -0.75% in the past week, with a monthly rise of 9.17% and a quarterly rise of 7.31%. The volatility ratio for the week is 2.17% while the volatility levels for the last 30 days are 2.49% for UiPath Inc. The simple moving average for the past 20 days is 2.84% for PATH’s stock, with a 4.23% simple moving average for the past 200 days.

Analysts’ Opinion of PATH

Many brokerage firms have already submitted their reports for PATH stocks, with BofA Securities repeating the rating for PATH by listing it as a “Underperform.” The predicted price for PATH in the upcoming period, according to BofA Securities is $10 based on the research report published on March 13, 2025 of the current year 2025.

Macquarie gave a rating of “Neutral” to PATH, setting the target price at $12 in the report published on June 03rd of the previous year.

PATH Trading at 12.61% from the 50-Day Moving Average

After a stumble in the market that brought PATH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.07% of loss for the given period.

#####

#####

Insider Trading

Reports are indicating that there were more than several insider trading activities at PATH starting from Dines Daniel, who sale 45,000 shares at the price of $13.11 back on Jun 06 ’25. After this action, Dines Daniel now owns 6,228,376 shares of UiPath Inc, valued at $589,779 using the latest closing price.

Dines Daniel, the CEO and Chairman of UiPath Inc, sale 45,000 shares at $13.17 during a trade that took place back on Jun 05 ’25, which means that Dines Daniel is holding 6,273,376 shares at $592,492 based on the most recent closing price.

Stock Fundamentals for PATH

Current profitability levels for the company are sitting at:

  • -0.11 for the present operating margin
  • 0.83 for the gross margin

The net margin for UiPath Inc stands at -0.05. The total capital return value is set at -0.08. Equity return is now at value -3.62, with -2.46 for asset returns.

Based on UiPath Inc (PATH), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 4.12.

Currently, EBITDA for the company is -162.57 million with net debt to EBITDA at 5.39. When we switch over and look at the enterprise to sales, we see a ratio of 4.38. The receivables turnover for the company is 2.65for trailing twelve months and the total asset turnover is 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.83.

Conclusion

In conclusion, UiPath Inc (PATH) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts

favicon-nh
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.